No, GLP-1 receptor agonists do not directly increase blood clot risk
Most mild reactions redness, mild pain, swelling clear within 2448 hours
In type 2 diabetes, the incretin effect is diminished and in parallel, post-prandial insulin secretion is deteriorating (2, 5)
It should not be confused with the more diffuse achiness associated with electrolyte depletion or protein deficiency
Calibrate is a year-long, structured weight-loss program that pairs GLP-1 medication like Ozempic, Wegovy, or Mounjaro with personalized coaching and a science-backed lifestyle curriculum
Case report A 52-year-old male patient presented with complaints of facial sagging, volume loss, and under-eye hollowness after losing 10kg over one year while on Ozempic (1.0mg weekly for 36 weeks) [3]